Edeltraud Flontas
Zinzino-asiakas
Tervetuloa! Minulla on hienoja kokemuksia tuotteistani, ja uskon, että sinäkin tulet ihastumaan niihin. Kerro minulle, mitä mieltä olet!
Investor relations
Financial calendar
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL): Zinzino announces Canary Islands as next step in its global expansion
keskiviikko 13. marraskuuta 2024 15.00
AvaaZINZINO AB (PUBL): Share subscription due to directed set-off issues
torstai 19. syyskuuta 2024 15.30
AvaaZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
torstai 27. kesäkuuta 2024 11.00
AvaaZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
maanantai 17. kesäkuuta 2024 11.00
AvaaZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
tiistai 11. kesäkuuta 2024 15.30
AvaaZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
perjantai 7. kesäkuuta 2024 12.00
AvaaZINZINO AB (PUBL): Announcement from the annual general meeting
maanantai 27. toukokuuta 2024 16.30
AvaaZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
sunnuntai 12. toukokuuta 2024 13.00
AvaaZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
perjantai 26. huhtikuuta 2024 8.00
AvaaZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
maanantai 29. tammikuuta 2024 10.00
AvaaZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
torstai 30. marraskuuta 2023 9.00
AvaaZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
perjantai 22. syyskuuta 2023 8.00
AvaaZINZINO AB (PUBL): Announcement from the annual general meeting
keskiviikko 31. toukokuuta 2023 16.20
AvaaZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
tiistai 2. toukokuuta 2023 8.00
AvaaZinzino AB (publ.) cancels warrants that have not been exercised
tiistai 2. toukokuuta 2023 8.00
AvaaZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
tiistai 7. maaliskuuta 2023 14.30
AvaaGrowing interest in personal health and customized supplements can be a great investment case
maanantai 28. marraskuuta 2022 14.30
AvaaZINZINO AB (PUBL): Share subscription due to directed offset issue
keskiviikko 26. lokakuuta 2022 16.30
AvaaZINZINO AB (PUBL): Announcement from the Annual General Meeting
tiistai 31. toukokuuta 2022 18.00
AvaaNotice of Annual General Meeting of Zinzino AB on May 31, 2022
perjantai 29. huhtikuuta 2022 12.00
AvaaZinzino announces the launch of Singapore as next step in their global expansion
torstai 7. huhtikuuta 2022 11.30
AvaaZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
keskiviikko 6. huhtikuuta 2022 9.30
AvaaZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
torstai 18. marraskuuta 2021 14.00
AvaaZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
tiistai 9. marraskuuta 2021 11.30
AvaaZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
torstai 9. syyskuuta 2021 13.00
AvaaZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
torstai 3. kesäkuuta 2021 11.00
AvaaNOTICE OF THE ANNUAL GENERAL MEETING OF ZINZINO AB (publ.)
keskiviikko 21. huhtikuuta 2021 14.23
AvaaZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
torstai 15. huhtikuuta 2021 15.00
AvaaZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
tiistai 6. huhtikuuta 2021 14.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2021
keskiviikko 3. maaliskuuta 2021 15.30
AvaaZINZINO AB (PUBL): Further expansions of the Zinzino global web shop
tiistai 15. joulukuuta 2020 16.15
AvaaZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
keskiviikko 16. syyskuuta 2020 10.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2020
perjantai 28. elokuuta 2020 8.00
AvaaZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
tiistai 5. toukokuuta 2020 12.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT NOVEMBER 2019
keskiviikko 11. joulukuuta 2019 10.30
AvaaZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
perjantai 25. lokakuuta 2019 16.40
AvaaZINZINO AB (PUBL): THE BOARD DECIDES TO ISSUE 200 000 STOCK OPTIONS
maanantai 15. lokakuuta 2018 15.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2018
torstai 11. lokakuuta 2018 13.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2018
torstai 5. heinäkuuta 2018 13.00
AvaaZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
perjantai 1. kesäkuuta 2018 11.00
AvaaZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
tiistai 15. toukokuuta 2018 8.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT FIRST QUARTER 2018
tiistai 10. huhtikuuta 2018 13.00
AvaaZINZINO LAUNCHES NEW PRODUCT: ENERGY BAR - DELICIOUS AND HEALTHY!
maanantai 12. maaliskuuta 2018 17.00
AvaaZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
keskiviikko 28. helmikuuta 2018 8.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
perjantai 19. tammikuuta 2018 18.00
AvaaInterim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
maanantai 13. marraskuuta 2017 8.30
AvaaZinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
perjantai 20. lokakuuta 2017 13.00
AvaaZINZINO AB (PUBL): CORRECTION: PRELIMINARY SALES REPORT THIRD QUARTER 2017
tiistai 10. lokakuuta 2017 17.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT THIRD QUARTER 2017
maanantai 9. lokakuuta 2017 11.00
AvaaInterim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
torstai 31. elokuuta 2017 9.00
AvaaZINZINO AB (PUBL): PRELIMINARY SALES REPORT SECOND QUARTER 2017
tiistai 4. heinäkuuta 2017 12.00
AvaaZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
perjantai 30. kesäkuuta 2017 15.00
AvaaZinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
perjantai 2. kesäkuuta 2017 16.00
AvaaZinzino begins selling in Switzerland ”Rich in capital and an important market”
tiistai 16. toukokuuta 2017 16.00
AvaaInterim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
keskiviikko 10. toukokuuta 2017 9.00
AvaaZinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
torstai 7. heinäkuuta 2016 16.24
AvaaZinzino expands sales to all EU countries “We see a huge potential”
tiistai 5. heinäkuuta 2016 11.10
AvaaInterim Report 1st January - 31st March 2016, Zinzino AB (publ)
perjantai 20. toukokuuta 2016 12.33
AvaaYear-End Report 1st January - 31st December 2015, Zinzino AB (publ)
maanantai 29. helmikuuta 2016 11.53
AvaaSweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
maanantai 22. helmikuuta 2016 8.00
AvaaZinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
perjantai 11. joulukuuta 2015 11.58
AvaaInterim Report July 1 - September 30, 2015 Zinzino AB (publ)
maanantai 23. marraskuuta 2015 15.28
AvaaSwedish Zinzino continues to grow internationally with its establishment in Canada
torstai 17. syyskuuta 2015 9.28
AvaaInterim report 1st January - 31st March 2015 Zinzino AB (publ)
perjantai 22. toukokuuta 2015 11.00
AvaaZinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
perjantai 6. maaliskuuta 2015 10.29
AvaaFinancial Statements 1 January - 31 December 2014, Zinzino AB (publ)
perjantai 27. helmikuuta 2015 14.39
AvaaThe stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
Jaa tämä sivu
Tai kopioi linkki